ScholarIQanswers from OpenAlex & ORCID
Frédéric Bernard
ResearcherPublications, citations & collaboration network
Frédéric Bernard is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Frédéric Bernard have?
ScholarIQindexed works
Frédéric Bernard has 392 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Frédéric Bernard have?
ScholarIQcitation count
Frédéric Bernard has 4,804 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Frédéric Bernard?
ScholarIQh-index
Frédéric Bernard has an h-index of 38 in OpenAlex.
What is the i10-index of Frédéric Bernard?
ScholarIQi10-index
Frédéric Bernard has an i10-index of 110 in OpenAlex.
What is the ORCID of Frédéric Bernard?
ScholarIQorcid
The ORCID for Frédéric Bernard is on the source record.
What is the OpenAlex record for Frédéric Bernard?
ScholarIQopenalex
The OpenAlex for Frédéric Bernard is on the source record.
What are the most-cited papers on Frédéric Bernard?
ScholarIQmost cited works
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies
Denis Caillot, Anne Thiébaut, Raoul Herbrecht, Stéphane de Botton, Arnaud Pigneux, Frédéric Bernard, Jérôme Larché, Françoise Monchecourt, S. Alfandari, L. Mahi
Some recent developments in mechanical activation and mechanosynthesis
Éric Gaffet, Frédéric Bernard, J.C. Niepce, F. Charlot, Christophe Gras, G. Le Caër, J.L. Guichard, P. Delcroix, Alain Mocellin, Olivier Tillement
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
Jean Donadieu, Frédéric Bernard, Max M. van Noesel, Mohamed Barkaoui, Odile Bardet, Rosamaria Mura, Maurizio Aricò, Christophe Piguet, Virginie Gandemer, Corinne Armari Alla, Niels Clausen, Éric Jeziorski, Anne Lambilliote, Sheila Weitzman, Jan‐Inge Henter, Cor van den Bos, the Salvage Group of the Histiocyte Society
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
Frédéric Millot, André Baruchel, Joëlle Guilhot, Arnaud Petit, Thierry Leblanc, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cécile Verite, Christian Berthou, Claire Galambrun, Frédéric Bernard, Karima Yacouben, Pierre Bordigoni, C. Edan, Yves Réguerre, Gérard Couillault, Françoise Méchinaud, Jean‐Michel Cayuela, François Guilhot
Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction
Frédéric Bernard, Caroline Thomas, Y. Bertrand, Martine Münzer, Judith Landman Parker, Marie Ouache, V. Minard Colin, Yves Pérel, Pascal Chastagner, C. Vermylen, Jean Donadieu